Definitive Contract HHSN268201200031C

Award Date 7/15/12
Potential Completion Date 10/31/17
Potential Value $8.8M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
San Francisco, CA 94118, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to The Regents of the University of California, San Francisco (UCSF) on March 29, 2010. The contract, valued at $1,930,904.73, is for a recovery act project to provide radiologic outcomes for the Osteoarthritis Initiative (OAI), which is sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The contract is a firm fixed price arrangement and...
This is a definitive cost-no-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) on June 15, 2010. The contract, valued at $2,025,201.08, supports research on hip morphology and limb-specific risk factors for radiographic hip osteoarthritis. UCSF, a leading academic medical center and research institution, is the prime contractor for this effort....
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) on February 2, 2009. The $3,319,012.92 Definitive Contract is for biomedical research and has a period of performance through July 31, 2016. The contract does not have a set-aside designation. As a leading academic medical center and research institution, UCSF has a strong...
This is a $1,379,807.12 federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF). The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. UCSF is a leading academic medical center and research institution that receives substantial federal funding for biomedical research, healthcare services,...
The Department of Health and Human Services National Institutes of Health awarded a definitive, cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for $6,657,300.68. The contract is for biomedical (basic) services and does not have a set-aside designation. UCSF, a public academic medical center and research university, is providing services through its Controller's Office division. The contract commenced on September 30, 2004 and is scheduled for completion...
This federal contract award to The Regents of the University of California, San Francisco (UCSF) is for the Sjögren's International Collaborative Clinical Alliance (SICCA) Biorepository. The $2,077,380.35 definitive contract was awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract, which has no set-aside designation, supports the continued operation and maintenance of the SICCA Biorepository, which...
The federal contract award was issued by the National Heart, Lung, and Blood Institute, a civilian agency, to the Regents of the University of California for biomedical (applied/exploratory) research. The award has a ceiling value of $1,134,369.00 and was issued on April 15, 2003 as a definitive cost-no-fee contract. The period of performance extends through September 29, 2011. This contract award is not associated with a set-aside and does not appear to be part of a larger contract vehicle...
This federal contract award, with an ID of HHSN268201400005C, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the Regents of the University of California, San Francisco (UCSF). The contract is for the "VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES" program, with a base period from November 15, 2013 to November 14, 2014 and a total completion date of November 14, 2016. The contract, which is...
This federal contract award is for biomedical research and services, with a total ceiling value of $10,607,389.80. The contract was awarded on March 28, 1996 to the prime contractor, The Regents of the University of California, San Francisco (UCSF), and has an ultimate completion date of February 14, 2013. The contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract is a definitive...
This is a $1,185,983.00 cost-no-fee delivery order contract awarded to The Regents of the University of California, San Francisco (UCSF) by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract is for the "SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III - SPIROMICS - TASK AREA B" project, which is not set aside for any specific business category. The contract has an...

This federal contract award, with an ID of HHSN268201200031C, was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to The Regents of the University of California, San Francisco (UCSF) for the Osteoarthritis Initiative Data Coordinating Center. The definitive, cost-no-fee contract has a ceiling value of $8,811,628.18 and a completion date of October 31, 2017. It does not have a set-aside designation.

Under this contract, UCSF will coordinate the Osteoarthritis Initiative, a long-term study of osteoarthritis. UCSF has subcontracted with Fisher Bioservices Inc. to maintain the central repository of biological specimens collected during the study, and with Synarc, Inc. to serve as the central Imaging Quality Assurance Center. The contract supports NHLBI's research efforts to understand and address osteoarthritis, a significant public health issue.

Generated 5/21/25, 10:12 AM